Omni Bio Pharmaceutical, Inc. announced that on January 31, 2013, the Board of Directors of the company appointed Michael E. Kamarck, age 61, as a director of the company. From 2010 to 2012, Dr. Kamarck was employed by Merck as President of Merck BioVentures and Senior Vice President of Vaccines and Biologics Manufacturing. From 2001 to 2009, he was employed by Wyeth, where he held various senior executive positions, including President, Technical Operations and Product Supply and was responsible for global technical operations for all of the Wyeth businesses.